Airway vasculature after mycoplasma infection: Chronic leakiness and selective hypersensitivity to substance P

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 280, Issue 2 24-2, 2001, Pages

  Kwan, M L ^a   Gomez A D ^a   Baluk, P ^a   Hashizume, H ^a   McDonald, D M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Endothelial cells; Evans blue; Fischer 344 rats; Inflammation; Mycoplasma pulmonis; Salmeterol; Vascular permeability; Wistar rats; 2 adrenoceptor agonists

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; EVANS BLUE; SALMETEROL; SEROTONIN; SUBSTANCE P; THROMBOCYTE ACTIVATING FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; MALE; MYCOPLASMA PULMONIS; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; TRACHEA MUCOSA; VASCULAR ENDOTHELIUM;

EID: 0035000764     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.280.2.l286     Document Type: Article

References (63)

1. Advenier C, Qian Y, Koune JD, Molimard M, Candenas ML, and Naline E. Formoterol and salbutamol inhibit bradykinin- and histamine-induced airway microvascular leakage in guinea-pig. Br J Pharmacol 105: 792-798, 1992.
2. Arvier PT, Chahl LA, and Ladd RJ. Modification by capsaicin and compound 48/80 of dye leakage induced by irritants in the rat. Br J Pharmacol 59: 61-68, 1977.
3. Ballard ST, Hill MA, and Meininger GA. Effect of vasodilation and vasoconstriction on microvascular pressures in skeletal muscle. Microcirc Endothelium Lymphatics 7: 109-131, 1991.
4. Ballard ST, Nations RH, and Taylor AE. Microvascular pressure profile of serosal vessels of rat trachea. Am J Physiol Heart Circ Physiol 262: H1303-H1304, 1992.
5. Baluk P, Bowden JJ, Lefevre PM, and McDonald DM. Upregulation of substance P receptors in angiogenesis associated with chronic airway inflammation in rats. Am J Physiol Lung Cell Mol Physiol 273: L565-L571, 1997.
6. Baluk P, Hirata A, Thurston G, Fujiwara T, Neal CR, Michel CC, and McDonald DM. Endothelial gaps: time course of formation and closure in inflamed venules of rats. Am J Physiol Lung Cell Mol Physiol 272: L155-L170, 1997.
7. 2-adrenergic receptor agonist formoterol reduces microvascular leakage by inhibiting endothelial gap formation. Am J Physiol Lung Cell Mol Physiol 266: L461-L468, 1994.
8. Bolton PB, Lefevre P, and McDonald DM. Salmeterol reduces early and late phase plasma leakage and leukocyte adhesion in rat airways. Am J Respir Crit Care Med 155: 1428-1435, 1997.
9. Borson DB, Brokaw JJ, Sekizawa K, McDonald DM, and Nadel JA. Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections. J Appl Physiol 66: 2653-2658, 1989.
10. Bowden JJ, Garland A, Baluk P, Lefevre P, Grady E, Vigna SR, Bunnett NW, and McDonald DM. Direct observation of substance P-induced internalization of NK1 receptors at sites of inflammation. Proc Natl Acad Sci USA 91: 8964-8968, 1994.
11. Brokaw JJ and White GW. Calcitonin gene-related peptide potentiates substance P-induced plasma extravasation in the rat trachea. Lung 170: 85-93, 1992.
12. Carroll N, Elliot J, Morton A, and James A. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis 147: 405-410, 1993.
13. Dahlqvist Å, Umemoto EY, Brokaw JJ, Dupuis M, and McDonald DM. Tissue macrophages associated with angiogenesis in chronic airway inflammation in rats. Am J Respir Cell Mol Biol 20: 237-247, 1999.
14. Dunnill MS. The pathology of asthma, with special references to changes in the bronchial mucosa. J Clin Pathol 13: 27-33, 1960.
15. Dvorak AM, Kohn S, Morgan ES, Fox P, Nagy JA, and Dvorak HF. The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leukoc Biol 59: 100-115, 1996.
16. Dvorak HF, Brown LF, Detmar M, and Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039, 1995.
17. Erjefält I and Persson CG. Inflammatory passage of plasma macromolecules into airway wall and lumen. Pulm Pharmacol 2: 93-102, 1989.
18. Flugge G. Regulation of monoamine receptors in the brain: dynamic changes during stress. Int Rev Cytol 195: 145-213, 2000.
19. Fujii E, Irie K, Uchida Y, Tsukahara F, and Muraki T. Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin. Naunyn Schmiedebergs Arch Pharmacol 350: 361-364, 1994.
20. Gao GC and Wei ET. Xenopsin, neurotensin, neurotensin(8-13) and N-acetyl-neurotensin(8-13) inhibit vascular leakage in rats after tissue injury. J Pharmacol Exp Ther 265: 619-625, 1993.
21. Garlow SJ, Morilak DA, Dean RR, Roth BL, and Ciaranello RD. Production and characterization of a specific 5-HT2 receptor antibody. Brain Res 615: 113-120, 1993.
22. Germonpre PR, Joos GF, Mekeirele K, and Pauwels RA. Role of the 5-HT receptor in neurogenic inflammation in Fisher 344 rat airways. Eur J Pharmacol 324: 249-255, 1997.
23. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, and McDonald DM. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156: 1363-1380, 2000.
24. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, and Jain RK. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 95: 4607-4612, 1998.
25. Huang HT, Haskell A, and McDonald DM. Changes in epithelial secretory cells and potentiation of neurogenic inflammation in the trachea of rats with respiratory tract infections. Anat Embryol (Berl) 180: 325-341, 1989.
26. Huber HL and Koessler KK. The pathology of bronchial asthma. Arch Intern Med 30: 689-760, 1922.
27. Ishizaka T, Ishizaka K, Orange RP, and Austen KF. Pharmacologic inhibition of the antigen-induced release of histamine and slow reacting substance of anaphylaxis (SRS-A) from monkey lung tissues mediated by human IgE. J Immunol 106: 1267-1273, 1971.
28. James AL, Pare PD, and Hogg JC. The mechanics of airway narrowing in asthma. Am Rev Respir Dis 139: 242-246, 1989.
29. Johnson M. The pharmacology of salmeterol. Lung 168, Suppl: 115-119, 1990.
30. Kirsch CM, Brokaw JJ, Prow DM, and White GW. Mechanism of platelet activating factor-induced vascular leakage in the rat trachea. Exp Lung Res 18: 447-459, 1992.
31. Kuwano K, Bosken CH, Pare PD, Bai TR, Wiggs BR, and Hogg JC. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 148: 1220-1225, 1993.
32. LeVeen HH and Fishman WH. Combination of Evans blue with plasma protein: its significance in capillary permeability studies, blood dye disappearance curves, and its use as a protein tag. Am J Physiol 151: 26-33, 1947.
33. Li X and Wilson JW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 156: 229-233, 1997.
34. Lindsey JR, Baker HJ, Overcash RG, Cassell GH, and Hunt CE. Murine chronic respiratory disease. Significance as a research complication and experimental production with Mycoplasma pulmonis. Am J Pathol 64: 675-708, 1971.
35. Lindsey JR and Cassell H. Experimental Mycoplasma pulmonis infection in pathogen-free mice. Models for studying mycoplasmosis of the respiratory tract. Am J Pathol 72: 63-90, 1973.
36. Majno G and Palade GE. Studies on inflammation. I. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol 11: 571-605, 1961.
37. McDonald DM. Respiratory tract infections increase susceptibility to neurogenic inflammation in the rat trachea. Am Rev Respir Dis 137: 1432-1440, 1988.
38. McDonald DM. Infections intensify neurogenic plasma extravasation in the airway mucosa. Am Rev Respir Dis 146: S40-S44, 1992.
39. McDonald DM. Endothelial gaps and permeability of venules in rat tracheas exposed to inflammatory stimuli. Am J Physiol Lung Cell Mol Physiol 266: L61-L83, 1994.
40. McDonald DM. Experimental models of bronchial reactivity: effect of airway infections. In: Mucosal Immunology (2nd ed.), edited by Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, and McGhee JR. San Diego, CA: Academic, 1999, p. 1177-1185.
41. McDonald DM, Schoeb TR, and Lindsey JR. Mycoplasma pulmonis infections cause long-lasting potentiation of neurogenic inflammation in the respiratory tract of the rat. J Clin Invest 87: 787-799, 1991.
42. McDonald DM, Thurston G, and Baluk P. Endothelial gaps as sites for plasma leakage in inflammation. Microcirculation 6: 7-22, 1999.
43. Michel CC and Neal CR. Openings through endothelial cells associated with increased microvascular permeability. Microcirculation 6: 45-54, 1999.
44. Nakao A, Watanabe T, Bitoh H, Imaki H, Suzuki T, Asano K, Taniguchi S, Nosaka K, Shimizu T, and Kurokawa K. cAMP mediates homologous downregulation of PAF receptor mRNA expression in mesangial cells. Am J Physiol Renal Physiol 273: F445-F450, 1997.
45. O'Donnell SR, Braun RA, Reid JJ, and Wholohan T. A histological method for studying the effects of drugs on mediator-induced airway microvascular leakage in rodents. J Pharmacol Methods 17: 205-217, 1987.
46. Olivenstein R, Du T, Xu LJ, and Martin JG. Microvascular leakage in the airway wall and lumen during allergen induced early and late responses in rats. Pulm Pharmacol Ther 10: 223-230, 1997.
47. Pullinger BD and Florey HW. Proliferation of lymphatics in inflammation. J Pathol Bacteriol 45: 157-170, 1937.
48. Rawson RA. The binding of T-1824 and structurally related diazo dyes by the plasma proteins. Am J Physiol 138: 708-717, 1943.
49. Roberts WG and Palade GE. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res 57: 765-772, 1997.
50. Rogers DF. Neurokinin receptors subserving airways secretion. Can J Physiol Pharmacol 73: 932-939, 1995.
51. Rogers DF, Boschetto P, and Barnes PJ. Plasma exudation. Correlation between Evans blue dye and radiolabeled albumin in guinea pig airways in vivo. J Pharmacol Methods 21: 309-315, 1989.
52. Schoefl GI. Studies on inflammation. III. Growing capillaries: their structure and permeability. Virchows Arch A Pathol Anat 337: 97-141, 1963.
53. Sear H, Allen TH, and Gregersen MI. Simultaneous measurement in dogs of plasma volume with I131 human albumin and T-1824 with comparisons of their long term disappearance from the plasma. Am J Physiol 175: 240-242, 1953.
54. Simionescu N. Cellular aspects of transcapillary exchange. Physiol Rev 63: 1536-1579, 1983.
55. Sulakvelidze I and McDonald DM. Anti-edema action of formoterol in rat trachea does not depend on capsaicin-sensitive sensory nerves. Am J Respir Crit Care Med 149: 232-238, 1994.
56. Taylor AE and Ballard ST. Microvascular function. Transvascular exchange of fluid in the airways. Am Rev Respir Dis 146: S24-S27, 1992.
57. Thurston G, Baluk P, Hirata A, and McDonald DM. Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding. Am J Physiol Heart Circ Physiol 271: H2547-H2562, 1996.
58. Thurston G, Murphy TJ, Baluk P, Lindsey JR, and McDonald DM. Angiogenesis in mice with chronic airway inflammation: strain-dependent differences. Am J Pathol 153: 1099-1112, 1998.
59. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, and McDonald DM. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286: 2511-2514, 1999.
60. Wedmore CV and Williams TJ. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature 289: 646-650, 1981.
61. Whelan CJ and Johnson M. Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin. Br J Pharmacol 105: 831-838, 1992.
62. Wilde WS, Hill JH, Wilson E, and Schielke GP. Exchange of free and albumin-bound Evans blue in interstitium of hamster kidney. Am J Physiol 220: 1991-1999, 1971.
63. Williams TJ. Interactions between prostaglandins, leukotrienes and other mediators of inflammation. Br Med Bull 39: 239-242, 1983.